A novel predictive model using changes in clinical and serum biomarkers and automated quantitative imaging for mCRPC patients treated with AR-directed therapy.
Melatonin Effects on Luteinizing Hormone in Postmenopausal Women: A Pilot Clinical Trial NCT00288262
The 20 participants completing the study had a mean age of 59 years (range 51–69). As expected due to random group assignment, baseline values of urinary LH excretion among the 3 groups were not ...
Men with a testosterone concentration less than 213 ng/dL had increased risk for all-cause mortality, regardless of luteinizing hormone concentration Men with low testosterone have increased risks for ...
Image: UnsplashA Melbourne startup is developing a new wearable device, in partnership with the University of Melbourne and ...
Rugiet offers personalized, clinician‑led testosterone and hormone treatments for men, including enclomiphene and TRT. Here’s how it works.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results